Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells

Cameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay · 2024

Read Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells by Cameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642316.txt.

Description

Cameron Noah Keighron and co-authors compare two cell lines used to model Parkinson's disease in the lab. Their 2024 paper notes that aging populations raise the stakes for neurodegenerative research. The cell models used to develop therapies must be robust and repeatable, or the pipeline of new treatments rests on sand.

Both cell types carry dopamine-related traits. Exposed to two standard toxins, one line, LUHMES, reacted consistently, showing dopamine markers, energy loss, and oxidative stress. The other, SH-SY5Y, resisted both insults, raising doubts about how well it mimics the disease. Electrical tests found similar firing, but LUHMES answered calcium signals more strongly. The authors back LUHMES as the sturdier model.

Catalog record

CREATORCameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11642316

Browse the full library · About the Tower of Babel